Market News

Seres Therapeutics, Inc. (MCRB) Analysts See $-0.72 EPS; Bank Of Nova Scotia Trust Company Lifted Its Cdn Imperial Bk Comm Toronto (CM) Holding

Seres Therapeutics, Inc. (NASDAQ:MCRB) Logo

Analysts expect Seres Therapeutics, Inc. (NASDAQ:MCRB) to report $-0.72 EPS on May, 3.They anticipate $0.09 EPS change or 14.29% from last quarter’s $-0.63 EPS. After having $-0.71 EPS previously, Seres Therapeutics, Inc.’s analysts see 1.41% EPS growth. The stock increased 1.96% or $0.15 during the last trading session, reaching $7.79. About 46,457 shares traded. Seres Therapeutics, Inc. (NASDAQ:MCRB) has declined 31.05% since April 16, 2017 and is downtrending. It has underperformed by 42.60% the S&P500.

Bank Of Nova Scotia Trust Company increased Cdn Imperial Bk Comm Toronto (CM) stake by 3.68% reported in 2017Q4 SEC filing. Bank Of Nova Scotia Trust Company acquired 10,447 shares as Cdn Imperial Bk Comm Toronto (CM)’s stock declined 9.42%. The Bank Of Nova Scotia Trust Company holds 294,490 shares with $28.69 million value, up from 284,043 last quarter. Cdn Imperial Bk Comm Toronto now has $38.02B valuation. The stock increased 0.45% or $0.39 during the last trading session, reaching $87.76. About 72,077 shares traded. Canadian Imperial Bank of Commerce (NYSE:CM) has risen 0.83% since April 16, 2017 and is uptrending. It has underperformed by 10.72% the S&P500.

Among 9 analysts covering Seres Therapeutics Inc (NASDAQ:MCRB), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Seres Therapeutics Inc had 25 analyst reports since July 21, 2015 according to SRatingsIntel. As per Tuesday, August 25, the company rating was maintained by Canaccord Genuity. The rating was maintained by Cantor Fitzgerald with “Buy” on Wednesday, August 30. The stock of Seres Therapeutics, Inc. (NASDAQ:MCRB) earned “Buy” rating by Canaccord Genuity on Monday, June 12. The stock of Seres Therapeutics, Inc. (NASDAQ:MCRB) has “Buy” rating given on Monday, January 25 by H.C. Wainwright. The stock has “Outperform” rating by Cowen & Co on Monday, June 6. FBR Capital maintained Seres Therapeutics, Inc. (NASDAQ:MCRB) rating on Friday, August 12. FBR Capital has “Outperform” rating and $23 target. The firm has “Neutral” rating given on Tuesday, July 21 by Bank of America. The company was maintained on Thursday, January 11 by Oppenheimer. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, July 22. The stock of Seres Therapeutics, Inc. (NASDAQ:MCRB) has “Buy” rating given on Friday, July 29 by H.C. Wainwright.

Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. The company has market cap of $316.65 million. The Company’s lead product candidate is SER-109, a bacterial spore ecology, which has completed Phase II clinical study to treat multiply recurrent Clostridium difficile infection . It currently has negative earnings. The firm also develops SER-287 that is in Phase Ib clinical study in patients with mild-to-moderate ulcerative colitis; and SER-262, a synthetic microbiome therapeutic candidate, which is in Phase Ib study in patients with primary CDI.

Among 15 analysts covering Canadian Imperial Bank Of Commerce (NYSE:CM), 6 have Buy rating, 2 Sell and 7 Hold. Therefore 40% are positive. Canadian Imperial Bank Of Commerce had 29 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, August 31 by BMO Capital Markets. The stock of Canadian Imperial Bank of Commerce (NYSE:CM) has “Outperform” rating given on Friday, December 1 by Credit Suisse. The rating was downgraded by TD Securities to “Hold” on Thursday, December 3. The firm has “Underperform” rating given on Tuesday, November 1 by Bank of America. The stock of Canadian Imperial Bank of Commerce (NYSE:CM) has “Buy” rating given on Thursday, August 24 by Canaccord Genuity. The rating was upgraded by Credit Suisse to “Underperform” on Monday, August 31. The rating was upgraded by Keefe Bruyette & Woods to “Mkt Perform” on Friday, February 24. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, August 26. The firm has “Market Perform” rating given on Friday, August 26 by BMO Capital Markets. Credit Suisse upgraded the shares of CM in report on Thursday, August 27 to “Underperform” rating.

Canadian Imperial Bank of Commerce (NYSE:CM) Ratings Chart

Leave a Reply

Your email address will not be published. Required fields are marked *